Several US state attorneys general will reportedly join the federal antitrust investigations of the pending multibillion dollar deals between DuPont and Dow Chemical and Bayer AG and Monsanto respectively.
Consolidation of these four already massive companies into two juggernauts—not to mention ChemChina’s $43 billion planned combination with chemical and seeds company Syngenta that cleared US scrutiny in August—will completely reshape the global seed and pesticide markets. If the deals are approved, Dow Chemical and DuPont will create one of the largest chemical makers in the US, while Bayer and Monsanto will form the largest seed and pesticide company in the world.
Reuters reports that about seven states, including California, have joined the probe of Dow’s planned merger with DuPont that would create a $130 billion chemical behemoth. A separate group of state attorneys general have also joined the Bayer-Monsanto investigation. The states are reportedly concerned that companies will increase pesticide and herbicide prices for farmers, and will have less incentive to compete and introduce better and cheaper products.
Full Content: EcoWatch
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas